Endoscopic Retrograde Cholangiopancreatography Access and Complication Rates After Cholecystectomy With Common Bile Duct Stones
Complication Rates Associated With Access or Not to Endoscopic Retrograde Cholangiopancreatography (ERCP) in Units Performing Cholecystectomy, When Common Bile Duct Stones Are Detected on Intraoperative Cholangiography
1 other identifier
observational
10,000
0 countries
N/A
Brief Summary
The aim of this retrospective, register-based study is to investigate whether access, or no access, to endoscopic retrograde cholangiopancreatography (ERCP) at a surgical unit is associated with the risk of complications in patients undergoing laparoscopic cholecystectomy with common bile duct stones detected on intraoperative cholangiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
Study Completion
Last participant's last visit for all outcomes
April 1, 2029
June 10, 2026
June 1, 2026
2 months
May 21, 2026
June 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complications
Overall complications from both the cholecystectomy and the endoscopic retrograde cholangiopancreatography (ERCP).
0- 30 days from the cholecystectomy, 0-30 days from any performed ERCP
Secondary Outcomes (5)
Length of hospital stay
0-100 days from the cholecystectomy, 0-100 days from any performed ERCP
Time from cholecystectomy to first treatment of common bile duct stones
0-100 days from the cholecystectomy
Unplanned ERCP after surgery due to CBDS
1-365 days
Unplanned readmission
0- 30 days from the cholecystectomy, 0-30 days from any performed ERCP
Mortality
0-30 days from the cholecystectomy, 0-30 days from any performed ERCP
Study Arms (2)
Cholecystectomy without access to endoscopic retrograde cholangiopancreatography (ERCP)
Patients, ≥18 years old, undergoing laparoscopic cholecystectomy with CBDS detected on IOC in Sweden 2015-2025 and registered in GallRiks. The cholecystectomy is performed in a unit without access to ERCP.
Cholecystectomy with access to ERCP
Patients, ≥18 years old, undergoing laparoscopic cholecystectomy with CBDS detected on IOC in Sweden 2015-2025 and registered in GallRiks. The cholecystectomy is performed in a unit with access to ERCP.
Interventions
The exposed group consists of patients undergoing laparoscopic and diagnosed with CBDS during cholecystectomy at a unit where ERCP is not available.
Eligibility Criteria
Patients, ≥18 years old, undergoing laparoscopic cholecystectomy with common bile duct stones detected on intraoperative cholangiography in Sweden 2015-2025 and registered in GallRiks.
You may qualify if:
- ≥18 years old
- Laparoscopic cholecystectomy with common bile duct stones (CBDS) detected on intraoperative cholangiography (IOC)
- Procedure registered in the Swedish Registry for Gallstone Surgery and ERCP (GallRiks) 2015-2025
You may not qualify if:
- Open surgery
- Conversion to open surgery
- Transgastric ERCP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Rystedt J, Montgomery A, Persson G. Completeness and correctness of cholecystectomy data in a national register--GallRiks. Scand J Surg. 2014 Dec;103(4):237-44. doi: 10.1177/1457496914523412. Epub 2014 Apr 15.
PMID: 24737852BACKGROUNDJohansson S, Runfors C, Sandblom G, Lindkvist B, Thorell A, Reuterwall Hansson M. Laparoscopic transcystic stenting with postoperative ERCP for the treatment of common bile duct stones: a safe alternative to intraoperative rendezvous ERCP-Data from the Swedish registry for gallstone surgery and ERCP (GallRiks). Surg Endosc. 2026 Jan 21;40(4):3040-7. doi: 10.1007/s00464-026-12565-3. Online ahead of print.
PMID: 41566062BACKGROUNDSyren EL, Sandblom G, Enochsson L, Eklund A, Isaksson B, Osterberg J, Eriksson S. Outcome of ERCP related to case-volume. Surg Endosc. 2022 Jul;36(7):5339-5347. doi: 10.1007/s00464-021-08915-y. Epub 2022 Jan 3.
PMID: 34981237BACKGROUNDSwahn F, Nilsson M, Arnelo U, Lohr M, Persson G, Enochsson L. Rendezvous cannulation technique reduces post-ERCP pancreatitis: a prospective nationwide study of 12,718 ERCP procedures. Am J Gastroenterol. 2013 Apr;108(4):552-9. doi: 10.1038/ajg.2012.470. Epub 2013 Feb 19.
PMID: 23419386BACKGROUNDNoel R, Arnelo U, Swahn F. Intraoperative versus postoperative rendezvous endoscopic retrograde cholangiopancreatography to treat common bile duct stones during cholecystectomy. Dig Endosc. 2019 Jan;31(1):69-76. doi: 10.1111/den.13222. Epub 2018 Jul 24.
PMID: 29947437BACKGROUNDMoller M, Gustafsson U, Rasmussen F, Persson G, Thorell A. Natural course vs interventions to clear common bile duct stones: data from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surg. 2014 Oct;149(10):1008-13. doi: 10.1001/jamasurg.2014.249.
PMID: 25133326BACKGROUNDTornqvist B, Stromberg C, Persson G, Nilsson M. Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study. BMJ. 2012 Oct 11;345:e6457. doi: 10.1136/bmj.e6457.
PMID: 23060654BACKGROUNDTornqvist B, Stromberg C, Akre O, Enochsson L, Nilsson M. Selective intraoperative cholangiography and risk of bile duct injury during cholecystectomy. Br J Surg. 2015 Jul;102(8):952-8. doi: 10.1002/bjs.9832. Epub 2015 Apr 28.
PMID: 25919401BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator. MD, PhD
Study Record Dates
First Submitted
May 21, 2026
First Posted
June 10, 2026
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
April 1, 2029
Last Updated
June 10, 2026
Record last verified: 2026-06